Strategic reports on peptide market gaps (e.g., post-patent-cliff generics), technology breakthroughs (AI-assisted synthesis), and investment analysis for emerging markets (India, MENA).
AI in Peptide Discovery: How DeepSeek Models Cut R&D Timelines by 40% The race to develop next-generation peptide therapeutics—from obesity
